Myovant Sciences Ltd. (MYOV)
NYSE: MYOV
· Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM
Myovant Sciences Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 100.23M | 104.82M | 116.49M | 57.57M | 54.44M | 77.9M | 41.06M | 24.61M | 1.38M | n/a | 33.33M |
Cost of Revenue | 34.23M | 27.36M | 22.93M | 17.74M | 16.33M | 11.19M | 6.29M | 1.97M | n/a | n/a | n/a |
Gross Profit | 66M | 77.46M | 93.56M | 39.83M | 38.11M | 66.72M | 34.77M | 22.64M | 1.38M | n/a | 33.33M |
Operating Income | -51.9M | -33.71M | -9.36M | -51.94M | -59.74M | -18.35M | -57.32M | -76.95M | -78.32M | -71.84M | -33.68M |
Interest Income | 1.59M | 1.02M | 486K | 136K | 70K | 100K | 78K | 33K | 32K | 38K | 108K |
Pretax Income | -56.42M | -37.51M | -13.07M | -55.3M | -63.15M | -21.74M | -60.75M | -80.41M | -75M | -67.2M | -32.19M |
Net Income | -57.63M | -45.62M | -21.24M | -59.28M | -63.45M | -21.59M | -61.66M | -81.36M | -73.85M | -67.06M | -32.86M |
Selling & General & Admin | 86.38M | 84.26M | 79.03M | 67.25M | 72.13M | 58.78M | 61.21M | 78.04M | 49.24M | 31.32M | 22.83M |
Research & Development | 31.52M | 26.92M | 23.89M | 24.52M | 25.73M | 26.28M | 30.88M | 21.55M | 30.45M | 40.52M | 44.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 117.9M | 111.17M | 102.92M | 91.76M | 97.85M | 85.06M | 92.09M | 99.59M | 79.7M | 71.84M | 67.01M |
Interest Expense | 6.12M | 4.81M | 4.2M | 3.49M | 3.48M | 3.49M | 3.5M | 3.49M | 2.61M | 2.12M | 2.18M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 152.12M | 138.53M | 125.85M | 109.5M | 114.18M | 96.25M | 98.39M | 101.55M | 79.7M | 71.84M | 67.01M |
Income Tax Expense | 1.21M | 8.11M | 8.16M | 3.99M | 296K | -149K | 911K | 952K | -1.15M | -134K | 672K |
Shares Outstanding (Basic) | 96.86M | 96.21M | 95.39M | 94.4M | 93.47M | 92.36M | 91.64M | 91.02M | 90.1M | 89.74M | 89.3M |
Shares Outstanding (Diluted) | 96.86M | 96.21M | 95.39M | 94.4M | 93.47M | 92.36M | 91.64M | 91.02M | 90.1M | 89.74M | 89.3M |
EPS (Basic) | -0.59 | -0.47 | -0.22 | -0.63 | -0.68 | -0.23 | -0.67 | -0.89 | -0.82 | -0.75 | -0.37 |
EPS (Diluted) | -0.59 | -0.47 | -0.22 | -0.63 | -0.68 | -0.23 | -0.67 | -0.89 | -0.82 | -0.75 | -0.37 |
EBITDA | -49.42M | -31.88M | -8.08M | -51.04M | -58.89M | -17.43M | -56.52M | -76.23M | -78.32M | -71.84M | -33.68M |
EBIT | -50.3M | -32.69M | -8.88M | -51.73M | -59.6M | -18.25M | -57.24M | -76.92M | -72.39M | -65.08M | -30M |
Depreciation & Amortization | 882K | 810K | 795K | 760K | 776K | 812K | 724K | 692K | 641K | 595K | 551K |